✦ LIBER ✦

The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs

✍ Scribed by H. A. BENCHAOUI; S. R. COX; R. P. SCHNEIDER; J. F. BOUCHER; R. G. CLEMENCE

Book ID: 108885214
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 621 KB
Volume: 30
Category: Article
ISSN: 0140-7783
DOI: 10.1111/j.1365-2885.2007.00877.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The neurokinin-1 antagonist activity of

The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model

✍ V. DE LA PUENTE-REDONDO; F. D. TINGLEY III; R. P. SCHNEIDER; M. A. HICKMAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Effect of maropitant, a neurokinin 1 rec

Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs

✍ Boscan, Pedro; Monnet, Eric; Mama, Khursheed; Twedt, David C.; Congdon, Jonathan 📂 Article 📅 2011 🏛 American Veterinary Medicine Association 🌐 English ⚖ 396 KB

Effect of epidural and intravenous use o

Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs

✍ Brittany M Alvillar; Pedro Boscan; Khursheed R Mama; Tatiana H Ferreira; Jonatha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Safety and efficacy of injectable and or

Safety and efficacy of injectable and oral maropitant, a selective neurokinin1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs

✍ D. S. RAMSEY; K. KINCAID; J. A. WATKINS; J. F. BOUCHER; G. A. CONDER; J. S. EAGL 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Efficacy and safety of maropitant, a sel

Efficacy and safety of maropitant, a selective neurokinin1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs

✍ G. A. CONDER; H. S. SEDLACEK; J. F. BOUCHER; R. G. CLEMENCE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Safety, pharmacokinetics and use of the

Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (CereniaTM) for the prevention of emesis and motion sickness in cats

✍ M. A. HICKMAN; S. R. COX; S. MAHABIR; C. MISKELL; J. LIN; A. BUNGER; R. B. McCAL 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB